Stay updated on Anetumab Ravtansine Multi-indication Clinical Trial

Sign up to get notified when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anetumab Ravtansine Multi-indication Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision: v3.6.5 is now shown, replacing the previous v3.6.4, indicating a minor site update to the page template.
    Difference
    0.0%
    Check dated 2026-08-11T15:45:06.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page’s revision tag in the footer was updated from v3.6.3 to v3.6.4, reflecting a small template/content update.
    Difference
    0.0%
    Check dated 2026-07-28T05:44:13.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The footer now displays Revision: v3.6.3, replacing the previous v3.6.2. This reflects a small platform update with no changes to the study details or navigation visible to users.
    Difference
    0.0%
    Check dated 2026-07-06T16:04:13.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.2 in the page footer, indicating a minor version update. The change does not modify page content or user-facing features.
    Difference
    0.0%
    Check dated 2026-06-29T08:40:45.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page now states that the study is no longer looking for participants, indicating recruitment has closed. Additional sections were added for How to Read a Study Record, Common Questions, How to Join a Study, and the Intervention/Treatment header formatting.
    Difference
    0.3%
    Check dated 2026-06-14T22:44:03.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.5.4 to v3.5.5, indicating a new page revision has been published. The update does not modify study details or page content.
    Difference
    0.0%
    Check dated 2026-06-07T15:55:49.000Z thumbnail image

Stay in the know with updates to Anetumab Ravtansine Multi-indication Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.